Several Australian oncology researchers have been highlighted as the most influential in the world in the Highly Cited Researchers 2022 list.
The list produced by research publication analytics company Clarivate identifies scientists who have published papers ranking in the top 1% by citations by peers in their field over the past ten years.
Among the 7225 Highly Cited Researcher designations across 21 fields of the sciences there are 466 named in the clinical sciences section.
The Australian oncology researchers include Associate Professor Matteo Carlino, a Medical Oncologist at Westmead and Blacktown Hospitals, Sydney a Clinical Senior Lecturer at the University of Sydney, and a Faculty Member at Melanoma Institute Australia. A/Prof Carlino has more than 360 publications with over 30,000 citations.
According to his biography, A/Prof Carlino is involved in the translational research program based at MIA and the Westmead Institute for Cancer Research. He is an investigator on multiple Phase I,II and III clinical trials in melanoma targeted and immunotherapy. He has completed a PhD examining predictors of response and mechanisms of resistance to BRAF and MEK inhibitor treated melanoma.
The list also features several Australian cancer clinicians who have featured in the Highly Cited Researchers in previous years including:
- Professor Georgina Long, (Melanoma), Melanoma Institute Australia, NSW.
- Professor Richard Scolyer, (Melanoma), Melanoma Institute Australia, NSW.
- Professor Richard Kefford, (Melanoma), Macquarie University, Sydney.
- Professor Sherene Loi, (Breast Cancer Genomics), Peter MacCallum Cancer Centre, Victoria.
- Professor Ben Solomon, (Lung Cancer), Peter MacCallum Cancer Centre, Victoria.
According to Clarivate there were 377 Highly Cited Researchers from Australia across all scientific field (from a total of 7225) and Australia was gaining share globally, moving from 4.0% in 2018 to a 4.7% share in 2022.
The United States was the institutional home for 2,764 Highly Cited Researchers 2022, which amounts to 38.3% of the total.
Mainland China was second with 1,169 Highly Cited Researchers, or 16.2%, up from 7.9% in 2018. The United Kingdom, with 579 researchers or 8.0%, was third, followed by Germany (369), Australia (337), Canada (226), The Netherlands (210), France (134), Switzerland (112) and Singapore (106).